Drug Shortage Report for EMERADE

Last updated on 2023-05-11 History
Report ID 192281
Drug Identification Number 02458446
Brand name EMERADE
Common or Proper name EMERADE
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) EPINEPHRINE
Strength(s) 0.3MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size n/a
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-05-03
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2023-05-11
Company comments Possible device failure
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2023-05-11 French Compare
v1 2023-05-11 English Compare

Showing 1 to 2 of 2